Drug use and dosing in chronic kidney disease
- PMID: 20052447
Drug use and dosing in chronic kidney disease
Abstract
One of the most important drug-related problems in patients with chronic kidney disease (CKD) is medication dosing errors. Many medications and their metabolites are eliminated through the kidney. Thus, adequate renal function is important to avoid toxicity. Patients with renal impairment often have alterations in their pharmacokinetic and pharmacodynamic parameters. The clearance of drugs eliminated primarily by renal filtration is decreased by renal disease. Therefore, special consideration should be taken when these drugs are prescribed to patients with impaired renal function. Despite the importance of dosage adjustment in patients with CKD, such adjustments are sometimes ignored. Physicians and pharmacists can work together to accomplish safe drug prescribing. This task can be complex and require a stepwise approach to ensure effectiveness, minimise further damage and prevent drug nephrotoxicity.
Similar articles
-
Dosing errors in prescribed antibiotics for older persons with CKD: a retrospective time series analysis.Am J Kidney Dis. 2014 Mar;63(3):422-8. doi: 10.1053/j.ajkd.2013.09.009. Epub 2013 Nov 1. Am J Kidney Dis. 2014. PMID: 24189475
-
Clinical Pharmacokinetics in Kidney Disease: Application to Rational Design of Dosing Regimens.Clin J Am Soc Nephrol. 2018 Aug 7;13(8):1254-1263. doi: 10.2215/CJN.05150418. Epub 2018 Jul 24. Clin J Am Soc Nephrol. 2018. PMID: 30042221 Free PMC article. Review.
-
Renal Drug Dosage Adjustment According to Estimated Creatinine Clearance in Hospitalized Patients With Heart Failure.Am J Ther. 2016 Jul-Aug;23(4):e1004-8. doi: 10.1097/01.mjt.0000434042.62372.49. Am J Ther. 2016. PMID: 24263162
-
Drug dosage adjustment of patients with impaired renal function at hospital discharge in a teaching hospital.J Nepal Health Res Counc. 2014 Jan;12(26):54-8. J Nepal Health Res Counc. 2014. PMID: 25574986
-
Principles of Kidney Pharmacotherapy for the Nephrologist: Core Curriculum 2021.Am J Kidney Dis. 2021 Sep;78(3):442-458. doi: 10.1053/j.ajkd.2021.02.342. Epub 2021 Jul 16. Am J Kidney Dis. 2021. PMID: 34275659 Review.
Cited by
-
Drug related problems in type 2 diabetes patients with hypertension: a cross-sectional retrospective study.BMC Endocr Disord. 2013 Jan 7;13:2. doi: 10.1186/1472-6823-13-2. BMC Endocr Disord. 2013. PMID: 23289895 Free PMC article.
-
Estimating renal function to reduce the risk of adverse drug reactions.Drug Saf. 2012 Jan;35 Suppl 1:47-54. doi: 10.1007/BF03319102. Drug Saf. 2012. PMID: 23446785 Review.
-
Drug-Related Problems and Associated Factors among Patients Admitted with Chronic Kidney Disease at Jimma University Medical Center, Jimma Zone, Jimma, Southwest Ethiopia: A Hospital-Based Prospective Observational Study.Int J Nephrol. 2019 Oct 20;2019:1504371. doi: 10.1155/2019/1504371. eCollection 2019. Int J Nephrol. 2019. PMID: 31772774 Free PMC article.
-
Use of renal risk drugs in a nation-wide Polish older adult population: an analysis of PolSenior database.BMC Geriatr. 2019 Mar 5;19(1):70. doi: 10.1186/s12877-019-1075-5. BMC Geriatr. 2019. PMID: 30836952 Free PMC article.
-
Is There Evidence of Any Safety Differences Among DPP-4 Inhibitors in the Treatment of People with Type 2 Diabetes Mellitus and Reduced GFR Due to Chronic Kidney Disease?Diabetes Ther. 2015 Mar;6(1):1-5. doi: 10.1007/s13300-015-0104-4. Epub 2015 Mar 18. Diabetes Ther. 2015. PMID: 25783754 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical